Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Pharmacol Ther. 2008 Jun;83(6):909-12. doi: 10.1038/clpt.2008.52. Epub 2008 Mar 26.

Development of translational pharmacokinetic-pharmacodynamic models.

Author information

  • 1Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA. dmager@buffalo.edu

Abstract

Contemporary models in the field of pharmacokinetic-pharmacodynamic (PK-PD) modeling often incorporate the fundamental principles of capacity limitation and operation of turnover processes to describe the time course of pharmacological effects in mechanistic terms. This permits the identification of drug- and system-specific factors that govern drug responses. There is considerable interest in utilizing mechanism-based PK-PD models in translational pharmacology, whereby in silico, in vitro, and preclinical data may be effectively coupled with relevant models to streamline the discovery and development of new therapeutic agents. These translational PK-PD models form the subject of this review.

PMID:
18388873
[PubMed - indexed for MEDLINE]
PMCID:
PMC2671003
Free PMC Article

Images from this publication.See all images (3)Free text

Figure 1
Figure 2
Figure 3
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Write to the Help Desk